Is Casualty Medical Systems Incorporated (NASDAQ:CASM)’s Fuel Running High? Reports Show Less Sellers

January 14, 2018 - By Clifton Ray

 Is Casualty Medical Systems Incorporated (NASDAQ:CASM)’s Fuel Running High? Reports Show Less Sellers

Investors sentiment decreased to 0.83 in 2017 Q3. Its down 0.37, from 1.2 in 2017Q2. It turned negative, as 2 investors sold CAS Medical Systems, Inc. shares while 4 reduced holdings. 2 funds opened positions while 3 raised stakes. 6.37 million shares or 4.99% more from 6.06 million shares in 2017Q2 were reported.
Acuta Cap Prtn Llc has invested 0.84% in CAS Medical Systems, Inc. (NASDAQ:CASM). Hightower Limited Liability Corp invested in 245,489 shares or 0% of the stock. Td Management Ltd Liability Com reported 38,175 shares. Rmb Management Ltd Liability Corporation reported 0% stake. Morgan Stanley holds 0% or 3,277 shares. Guggenheim Cap Lc accumulated 13,692 shares. Royal Bank & Trust Of Canada accumulated 20 shares or 0% of the stock. Vanguard Gp, a Pennsylvania-based fund reported 531,881 shares. Wells Fargo Communication Mn holds 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM) for 227 shares. Blackrock, a New York-based fund reported 11,354 shares. Manatuck Hill Prtn Ltd Liability Corp holds 50,000 shares. California Public Employees Retirement System holds 0% or 10,400 shares. 1492 Capital Mgmt Ltd Co, a Wisconsin-based fund reported 42,346 shares. Renaissance Tech Ltd Liability stated it has 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). Northern invested in 0% or 25,101 shares.

The stock of Casualty Medical Systems Incorporated (NASDAQ:CASM) registered a decrease of 3.78% in short interest. CASM’s total short interest was 249,700 shares in January as published by FINRA. Its down 3.78% from 259,500 shares, reported previously. With 58,900 shares average volume, it will take short sellers 4 days to cover their CASM’s short positions. The short interest to Casualty Medical Systems Incorporated’s float is 1.27%.

The stock decreased 4.67% or $0.05 during the last trading session, reaching $1.02. About 31,319 shares traded. CAS Medical Systems, Inc. (NASDAQ:CASM) has declined 47.56% since January 14, 2017 and is downtrending. It has underperformed by 64.26% the S&P500.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $27.88 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

More recent CAS Medical Systems, Inc. (NASDAQ:CASM) news were published by: Globenewswire.com which released: “CASMED Names Kimberly Strusky Executive Vice President of US Sales” on October 05, 2015. Also Seekingalpha.com published the news titled: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2017 Results – Earnings Call …” on May 03, 2017. Seekingalpha.com‘s news article titled: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q3 2017 Results – Earnings Call …” with publication date: November 12, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: